Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » 10x Genomics Countersues Bio-Rad Laboratories in Latest Patent Infringement Lawsuit

10x Genomics Countersues Bio-Rad Laboratories in Latest Patent Infringement Lawsuit

May 18, 2020
|
staff reporter

NEW YORK – 10x Genomics has countersued Bio-Rad Laboratories in a US District Court patent infringement suit.

Last week, 10x responded to Bio-Rad's allegations that 10x's Next GEM microfluidic chips infringe US Patent No. 10,190,115, "Methods and compositions for nucleic acid analysis" which covers the partitioning of a sample into droplets, in some cases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

J&J Vaccine Benefits Outweighs Risk, EMA Says

The European Medicines Agency recommends that a warning about the possibility of blood clots be added to the product information.

Organoids in Space

According to Agence France Presse, astronauts who are to arrive soon at the International Space Station are to study the effect of microgravity on brain organoids and more.

Fall of Salmon Diversity

A new study finds that farmed fish have led to a decline in genetic diversity among Atlantic salmon, the Guardian reports.

Cell Studies on SARS-CoV-2 B.1.1.7 Introductions, Microbiome HGT, Heterogeneity Within Tumors

In Cell this week: analysis of SARS-CoV-2 B.1.1.7 introductions to the US, increased horizontal gene transfer higher in gut microbiomes linked to industrialization, and more.

What's Popular?

In Business News

  1. European Union to Review Illumina's Planned Grail Acquisition Under New Guidance

  2. Nanopore Sequencing Firm Armonica Technologies Progresses Towards Single-Base Detection

    Premium

  3. Roche Diagnostics Q1 Sales Climb 50 Percent

  4. Abbott Q1 Diagnostics Revenues More Than Double on COVID-19 Testing

  5. Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.